Hexal moves into tenders
Generics Bulletin, p.23, February 03, 2012
When Germany’s AOK group of statutory health insurance funds announced the results of its seventh round of tender contracts in late- November last year, Sandoz grabbed the headlines for more than one reason. Novartis’ generics business led the way by capturing 145 of the 737 regional supply contracts awarded, ahead of Stada in second place on 127 contracts and Teva in third with 118 of the contracts handed out by the fund, which accounts for just over a third of Germany’s statutory health insurance market.
